Hotspots and trends in multiple myeloma bone diseases: A bibliometric visualization analysis
Zhaomeng Hou1,2, Ping Jiang3, Shaoting Su1
1Guangxi University of Chinese Medicine, Nanning, China.
Frontiers in Pharmacology
|October 31, 2022
Summary
This bibliometric analysis reveals key research trends in multiple myeloma bone disease over 20 years. It highlights growing interest in diagnosis, pathogenesis, and targeted therapies for this complex condition.
Area of Science:
- Bibliometric analysis
- Oncology
- Hematology
Background:
- Multiple myeloma bone disease is a significant complication.
- Understanding research trends is crucial for advancing treatment.
Purpose of the Study:
- To explore research hotspots and trends in multiple myeloma bone disease over the past two decades.
- To provide a bibliometric visualization analysis of the field.
Main Methods:
- Data retrieved from Web of Science Core Collection (2002-2021).
- Analysis using CiteSpace 5.8.R3, Scimago Graphica 1.0.24, and Literature Metrology Online Analysis Platform.
- Bibliometric visualization techniques applied.
Main Results:
- 6,168 publications analyzed, with increasing annual output and citations.
- United States leads in publications; Mayo Clinic is a major contributor.
- Key research frontiers include disease diagnosis, prognosis, pathogenesis, imaging, and targeted therapy.
- Recent hotspots include transplantation, drug resistance, and mesenchymal stem cells.
Conclusions:
- Bibliometric analysis effectively identifies research hotspots and trends in multiple myeloma bone disease.
- The study offers valuable insights for future research directions in the field.
More Related Videos
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
397
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
397
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K